Your browser doesn't support javascript.
loading
Use of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data.
Earla, Jagadeswara R; Paranjpe, Rutugandha; Kachru, Nandita; Hutton, George J; Aparasu, Rajender R.
Afiliação
  • Earla JR; Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, TX, USA. Electronic address: Jagadesh.e.rao@gmail.com.
  • Paranjpe R; Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, TX, USA. Electronic address: rutugandha89@gmail.com.
  • Kachru N; Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, TX, USA. Electronic address: nanditakachru@gmail.com.
  • Hutton GJ; Baylor College of Medicine, Houston, TX, USA. Electronic address: ghutton@bcm.edu.
  • Aparasu RR; Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, TX, USA. Electronic address: rraparasu@uh.edu.
Res Social Adm Pharm ; 16(12): 1670-1676, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32171597
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article